期刊文献+

阴沟肠杆菌对β内酰胺类和氨基糖苷类抗生素的耐药性及其耐药基因

Drug resistance of Enterobacter cloacae to β-lactamas and aminoglycosides and its genotypes
暂未订购
导出
摘要 目的 调查临床分离的阴沟肠杆菌对β内酰胺类和氨基糖苷类抗生索的耐药性及其耐药基因。方法 采用ATB药敏试验板微量肉汤法,对20株临床分离的阴沟肠杆菌进行抗生素敏感试验,PCR方法检测TEM、SHV、CTX-M、OXA-1群、PER、VEB、GES、DHA、MIR等9种BLAs基因与aac(3)-Ⅰ、aac(3)-Ⅱ、aac(6′)-Ⅰ、aac(6′)-Ⅱ、ant(3″)-Ⅰ,ant(2″)-Ⅰ等6种AMEs基因。结果 该20株菌对亚胺培南和美罗培南均敏感,对其他抗生素的耐药率在50.0%~85.0%之间。MIR、DHA和TEM基因的阳性率分别为70.0%、45.0%和55.0%。而其余BIAs基因均阴性。19株(95.0%)检出氨基糖苷类修饰酶基因:ant(6′)-Ⅰ、ant(3″)-Ⅰ、ant(2″)-Ⅰ、ant(6′)-Ⅱ、aac(3)-Ⅱ基因的阳性率分别为50.0%、15.0%、10.0%、5.0%、5.0%,而anc(3),Ⅰ基因均阴性。结论 临床分离的阴沟肠杆菌多重耐药严重,其8内酰胺酶基因和氨基糖苷类修饰酶基因携带率高。 Objective To investigate the drug resistance of Enterobacter cloacae isolated from clinical samples to β-lactamas and aminoglycosides and its genotypes. Methods Antimicrobial susceptibility test were performed by microdiluted method, BLAs and AMEs genes were detected by PCR method for 20 strains of Enterobacter cloacae isolated from clinical samples. Results All strains were susceptible to imipenem and meropenem, the resistant rates to other antimicrobial agents of them were between 50.0% and 85.0%. The positive rate of MIR,DHA and TEM genes was 70.0% ,45.0% and 55.0%, respectively. But other BLAs gene was not found. AMEs genes were found in 19 strains(95.0% ). The positive rate of aac (6′ }-Ⅰ ,ant(3″)-Ⅰ ,ant(2")-Ⅰ , aac (6′)-Ⅰ, aac ( 3)-Ⅱgenes was 50.0%, 15.0%, 10.0%, 5.0% and 5.0%, respectively. But the aae ( 3 )-Ⅰ gene was not found. Condusion There ate multiple-drug resistance and high positive rate of BLAs and AMEs genes in Enterobacter cloacae isolated from clinical samples.
出处 《现代实用医学》 2006年第3期152-153,186,共3页 Modern Practical Medicine
关键词 抗药性 多药 基因型 Β内酰胺类 氨基糖苷类 阴沟肠杆菌 抗生素 Enterobacter cloacaes Drug resistance, multipe Genotype β-lactams Aminoglycosides
  • 相关文献

参考文献9

二级参考文献42

  • 1徐英春,陈民钧.AmpC酶与革兰阴性菌的耐药特征[J].中华微生物学和免疫学杂志,2001,21(S1):18-20. 被引量:24
  • 2糜祖煌,黄支密,秦玲.鲍氏不动杆菌耐药性和氨基糖苷类修饰酶、β-内酰胺酶基因研究[J].中华医院感染学杂志,2004,14(9):968-971. 被引量:136
  • 3Livermore DM, Williams JD. β-lactams: mode of action and mechanisms of bacterial resistance. In: Lorian V, eds. Antibiotics in laboratory medicine. 4th ed. Baltimore:Williams & Wilkins, 1996. 502-578.
  • 4Sanders CC. β-lactamase of gram negative bacteria: new challenges for new drugs. Clin Infect Dis, 1992,14:1089-1099.
  • 5Naumiuk L, Samet A, Dziemaszkiewicz E. Cefepime in vitro activity against derepressed extended-spectrum β-lactamase(ESBL)-producing and non-ESBL-producing Enterobacter cloacae by a disc diffusion method. J Antimicrob Chemother, 2001,48:321-322.
  • 6National Committee for Clinical Laboratory Standards. Performance standards for antimicrobial susceptibility testing. 9th informational supplement(M100-S9). Wayne:NCCLS,1999.
  • 7Coudron PE,Moland ES, Thomson KS. Occurrence and detection of AmpC β-lactamases among Escherichia coli,Klebsiella pneumoniae,and Proteus mirabilis isolates at a veterans medical center. J Clin Microbiol, 2000, 38:1791-1796.
  • 8Tzelepi E, Giakkoupi P, Sofianou D, et al. Detection of extended-spectrum β-lactamases in clinical isolates of Enterobacter cloacae and Enterobacter aerogenes. J Clin Microbiol, 2000,38:542-546.
  • 9Chanal C, Sirot D, Romaszko JP, et al. Survey of extended-spectrum β-lactamases among Enterobacteriaceae. J Antimicrob Chemother, 1996, 38:127-132.
  • 10Coudron PE,Moland ES, Sanders CC. Occurrence and detection of extended-spectrum β-lactamases in members of the family Enterobacteriaceae at a veterans medical center: seek and you may find. J Clin Microbiol, 1997, 35:2593-2597.

共引文献614

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部